GlassScriptPhysician profile
Rajinder Bajwa
NPI 1831419654
$6,507.42
in general payments reported to CMS, 2019-2025
26 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $731 · 2020: $698 · 2021: $419 · 2022: $757 · 2023: $2,467 · 2024: $957 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,531 · Travel and Lodging: $1,200 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,531.41 |
| Travel and Lodging | $1,199.97 |
| Education | $170.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adaptive Biotechnologies Corporation | $1,408.46 | 2023 | Clonoseq |
| Gilead Sciences, INC. | $1,303.29 | 2019-2025 | Biktarvy |
| Abbvie INC. | $698.96 | 2019-2025 | Dalvance, Mavyret, Teflaro |
| Viiv Healthcare Company | $462.98 | 2022-2025 | Dovato, Apretude, Cabenuva |
| Smith+Nephew, INC. | $377.97 | 2019-2025 | Collagenase Santyl, Acticoat 4" X 4", Allevyn Life L 15.4x15.4 Ctn10 |
| Organogenesis INC. | $315.64 | 2019-2023 | Puraply Antimicrobial, Puraply |
| Misonix INC | $238.35 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $207.73 | 2021-2024 | Nuzyra |
| Merck Sharp & Dohme LLC | $188.41 | 2019-2025 | Zerbaxa, Dificid |
| Allergan, INC. | $176.13 | 2019-2020 | |
| Bioventus LLC | $147.83 | 2022 | |
| Astellas Pharma US INC | $144.94 | 2023 | |
| Novartis Pharmaceuticals Corporation | $133.59 | 2024 | |
| Tactile Systems Technology INC | $132.39 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Insmed, INC. | $117.52 | 2022-2024 | Arikayce |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Comsort, INC | $100.00 | 2019 | |
| Hydrofera LLC | $68.37 | 2022-2023 | Hydrofera Blue Ready - Border |
| Advanced Oxygen Therapy INC. | $53.05 | 2023-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Integra Lifesciences Corporation | $44.66 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Jazz Pharmaceuticals INC. | $39.42 | 2019 | |
| Osiris Therapeutics INC. | $32.64 | 2019 | |
| Kci USA, INC. | $28.39 | 2019-2023 | Kerramax Care, Activ.A.C. |
| Melinta Therapeutics, LLC | $27.98 | 2019-2021 | |
| Convatec INC. | $22.88 | 2022 | |
| Redhill Biopharma INC. | $22.04 | 2020 | |
| Lifenet Health | $13.80 | 2025 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajinder Bajwa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.